Benzinga··Law Offices Of Howard G. SmithSoleno Therapeutics Faces Securities Fraud Suit Over DCCR Drug; Deadline Looms
Soleno Therapeutics ($SLNO) faces securities fraud lawsuit over DCCR drug for Prader-Willi syndrome. Stock plunged following safety concerns, patient death, and weak Q3 results.
SLNOsecurities fraudclass action lawsuit